AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system

Jana Schuck, Torsten Gursinsky, Vitantonio Pantaleo, Jozsef Burgyán, Sven Erik Behrens

Research output: Contribution to journalArticle

57 Citations (Scopus)


AGO/RISC-mediated antiviral RNA silencing, an important component of the plant's immune response against RNA virus infections, was recapitulated in vitro. Cytoplasmic extracts of tobacco protoplasts were applied that supported Tombusvirus RNA replication, as well as the formation of RNA-induced silencing complexes (RISC) that could be functionally reconstituted with various plant ARGONAUTE (AGO) proteins. For example, when RISC containing AGO1, 2, 3 or 5 were programmed with exogenous siRNAs that specifically targeted the viral RNA, endonucleolytic cleavages occurred and viral replication was inhibited. Antiviral RNA silencing was disabled by the viral silencing suppressor p19 when this was present early during RISC formation. Notably, with replicating viral RNA, only (+)RNA molecules were accessible to RISC, whereas (-)RNA replication intermediates were not. The vulnerability of viral RNAs to RISC activity also depended on the RNA structure of the target sequence. This was most evident when we characterized viral siRNAs (vsiRNAs) that were particularly effective in silencing with AGO1-or AGO2/RISC. These vsiRNAs targeted similar sites, suggesting that accessible parts of the viral (+)RNA may be collectively attacked by different AGO/RISC. The in vitro system was, hence, established as a valuable tool to define and characterize individual molecular determinants of antiviral RNA silencing.

Original languageEnglish
Pages (from-to)5090-5103
Number of pages14
JournalNucleic acids research
Issue number9
Publication statusPublished - May 2013

ASJC Scopus subject areas

  • Genetics

Fingerprint Dive into the research topics of 'AGO/RISC-mediated antiviral RNA silencing in a plant in vitro system'. Together they form a unique fingerprint.

  • Cite this